Charles Schwab’s La Jolla Pharmaceutical Company LJPC Stock Holding History
Bought
Maintained
Sold
Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
---|---|---|---|---|---|---|---|---|
2021
Q2 | – | Sell |
-181,934
| Closed | -$772K | – | 3647 |
|
2021
Q1 | $772K | Sell |
181,934
-7,851
| -4% | -$33.3K | ﹤0.01% | 2938 |
|
2020
Q4 | $737K | Hold |
189,785
| – | – | ﹤0.01% | 2868 |
|
2020
Q3 | $765K | Sell |
189,785
-88,369
| -32% | -$356K | ﹤0.01% | 2742 |
|
2020
Q2 | $1.19M | Buy |
278,154
+143,700
| +107% | +$612K | ﹤0.01% | 2575 |
|
2020
Q1 | $565K | Buy |
134,454
+15,666
| +13% | +$65.8K | ﹤0.01% | 2671 |
|
2019
Q4 | $467K | Sell |
118,788
-10,577
| -8% | -$41.6K | ﹤0.01% | 2842 |
|
2019
Q3 | $1.14M | Buy |
129,365
+2,667
| +2% | +$23.5K | ﹤0.01% | 2531 |
|
2019
Q2 | $1.17M | Buy |
126,698
+26,194
| +26% | +$242K | ﹤0.01% | 2521 |
|
2019
Q1 | $647K | Sell |
100,504
-14,305
| -12% | -$92.1K | ﹤0.01% | 2671 |
|
2018
Q4 | $1.08M | Buy |
114,809
+8,229
| +8% | +$77.6K | ﹤0.01% | 2520 |
|
2018
Q3 | $2.15M | Sell |
106,580
-3,000
| -3% | -$60.4K | ﹤0.01% | 2407 |
|
2018
Q2 | $3.2M | Buy |
109,580
+23,150
| +27% | +$675K | ﹤0.01% | 2208 |
|
2018
Q1 | $2.57M | Buy |
86,430
+11,132
| +15% | +$332K | ﹤0.01% | 2233 |
|
2017
Q4 | $2.42M | Buy |
75,298
+10,639
| +16% | +$342K | ﹤0.01% | 2242 |
|
2017
Q3 | $2.25M | Buy |
64,659
+36,580
| +130% | +$1.27M | ﹤0.01% | 2249 |
|
2017
Q2 | $836K | Buy |
28,079
+6,500
| +30% | +$194K | ﹤0.01% | 2521 |
|
2017
Q1 | $645K | Hold |
21,579
| – | – | ﹤0.01% | 2559 |
|
2016
Q4 | $379K | Hold |
21,579
| – | – | ﹤0.01% | 2756 |
|
2016
Q3 | $514K | Hold |
21,579
| – | – | ﹤0.01% | 2604 |
|
2016
Q2 | $346K | Hold |
21,579
| – | – | ﹤0.01% | 2732 |
|
2016
Q1 | $452K | Hold |
21,579
| – | – | ﹤0.01% | 2616 |
|
2015
Q4 | $583K | Buy |
21,579
+5,000
| +30% | +$135K | ﹤0.01% | 2583 |
|
2015
Q3 | $461K | Hold |
16,579
| – | – | ﹤0.01% | 2656 |
|
2015
Q2 | $407K | Buy |
+16,579
| New | +$407K | ﹤0.01% | 2756 |
|